D'ONOFRIO, Mirko
 Distribuzione geografica
Continente #
NA - Nord America 33.288
EU - Europa 26.495
AS - Asia 17.277
SA - Sud America 2.534
Continente sconosciuto - Info sul continente non disponibili 638
AF - Africa 497
OC - Oceania 63
AN - Antartide 1
Totale 80.793
Nazione #
US - Stati Uniti d'America 31.277
RU - Federazione Russa 9.019
SG - Singapore 6.654
GB - Regno Unito 6.321
CN - Cina 5.444
IT - Italia 3.047
BR - Brasile 2.008
DE - Germania 1.998
SE - Svezia 1.482
CA - Canada 1.450
VN - Vietnam 1.391
HK - Hong Kong 1.313
FR - Francia 1.213
IE - Irlanda 1.183
FI - Finlandia 1.030
KR - Corea 542
BD - Bangladesh 378
IN - India 283
UA - Ucraina 269
TR - Turchia 246
JP - Giappone 217
NL - Olanda 169
AR - Argentina 167
MX - Messico 139
NG - Nigeria 119
ES - Italia 116
PL - Polonia 111
ID - Indonesia 109
IQ - Iraq 106
ZA - Sudafrica 96
AT - Austria 87
CR - Costa Rica 82
CO - Colombia 79
EC - Ecuador 75
BE - Belgio 65
PK - Pakistan 65
IR - Iran 60
VE - Venezuela 60
IL - Israele 54
LT - Lituania 53
AU - Australia 52
CL - Cile 50
UZ - Uzbekistan 50
TT - Trinidad e Tobago 49
GT - Guatemala 46
PH - Filippine 45
MA - Marocco 44
SA - Arabia Saudita 44
SV - El Salvador 40
EG - Egitto 39
HN - Honduras 38
BJ - Benin 37
AE - Emirati Arabi Uniti 36
CH - Svizzera 34
JM - Giamaica 34
PR - Porto Rico 34
CZ - Repubblica Ceca 33
TG - Togo 33
NI - Nicaragua 32
PE - Perù 31
TN - Tunisia 31
CW - ???statistics.table.value.countryCode.CW??? 30
MY - Malesia 30
JO - Giordania 29
PY - Paraguay 29
KE - Kenya 26
RO - Romania 23
RS - Serbia 21
NP - Nepal 20
AZ - Azerbaigian 19
EE - Estonia 19
LV - Lettonia 19
BG - Bulgaria 18
BO - Bolivia 18
DK - Danimarca 18
PT - Portogallo 18
KZ - Kazakistan 17
TW - Taiwan 17
DZ - Algeria 16
GP - Guadalupe 15
GR - Grecia 15
HR - Croazia 15
HU - Ungheria 15
OM - Oman 15
AL - Albania 14
UY - Uruguay 14
ET - Etiopia 13
BB - Barbados 12
NO - Norvegia 12
PA - Panama 12
SK - Slovacchia (Repubblica Slovacca) 12
AM - Armenia 11
EU - Europa 11
SI - Slovenia 11
LB - Libano 10
DO - Repubblica Dominicana 9
KG - Kirghizistan 9
SN - Senegal 9
QA - Qatar 8
TH - Thailandia 8
Totale 80.046
Città #
Southend 4.518
Ashburn 4.341
Singapore 3.567
Moscow 3.060
San Jose 2.856
Chandler 2.647
Dallas 2.562
Jacksonville 2.027
Woodbridge 1.535
Hong Kong 1.280
Dublin 1.175
Council Bluffs 1.150
Ann Arbor 1.101
Verona 1.024
Munich 984
Beijing 951
Montréal 889
The Dalles 807
Houston 781
Mcallen 738
New York 516
Los Angeles 488
Ho Chi Minh City 461
Wilmington 458
Lawrence 429
Princeton 429
Jinan 426
Nanjing 378
Hanoi 310
Santa Clara 300
Shenyang 298
Helsinki 293
Buffalo 276
Milan 269
São Paulo 252
Tianjin 205
Tokyo 186
Columbus 173
Hebei 162
Toronto 159
Orem 157
Redondo Beach 155
Bologna 143
London 143
Montreal 138
Haikou 137
Zhengzhou 133
Ningbo 131
Rome 131
Changsha 129
Guangzhou 123
Turku 117
Nanchang 116
Taizhou 114
Abuja 112
Hangzhou 108
Lancaster 107
Phoenix 106
Sindelfingen 98
Denver 97
Brooklyn 96
Frankfurt am Main 96
Warsaw 96
Chennai 95
Chicago 92
Seattle 88
Boardman 84
Jiaxing 83
San Francisco 83
Taiyuan 77
Da Nang 73
Washington 72
Amsterdam 71
San José 71
Atlanta 70
Rio de Janeiro 69
Seoul 67
Johannesburg 62
Brussels 60
Mexico City 58
Kent 57
Norwalk 56
Redwood City 55
Lanzhou 54
Poplar 54
Redmond 54
Haiphong 53
Stockholm 53
Las Vegas 51
Manchester 49
Vienna 49
Boston 48
Shanghai 48
Belo Horizonte 45
Tashkent 45
Nuremberg 43
Paris 42
Fuzhou 41
Falkenstein 39
Charlotte 38
Totale 49.493
Nome #
Acoustic Radiation Force Impulse (ARFI) of the Pancreas 569
Contrast-enhanced ultrasonography (CEUS) of the pancreas 558
Diffusion-weighted Imaging: An Additional Value for the MRI Study of Pancreatic Neoplasms 486
DWI and dynamic MRI in the study of intraductal papillary mucinous neoplasms (IPMNs): pathological comparison with tumour grade 471
Role of fistulography in postoperative pancreas fistulas 468
Comaparison of Contrast-enhanced ultrasonography an magnetic resonance imaging in displaying anatomic features of cystic pancreatic masses 443
Hepatic adenoma: contrast-enhanced behaviour at yery low MI CEUS is helpful in characterization? 439
Percutaneous Radiofrequency Ablation of Pancreatic Adenocarcinoma 439
First Results of 64-row MDCT Perfusion in the Characterization of Focal Solid Pancreatic Lesions 412
CEUS (Postgraduate Educational Programme: Tips and tricks for abdominal ultrasound) 396
Accuracy of ultrasound in the detection of liver fibrosis in chronic viral hepatitis. 382
Comparison of Contrast-enhanced Ultrasonography and MRI in Displaying Anatomic Features of Pancreatic Serous Cystoadenomas 344
Somatostatin analogs for resectable pancreatic neuroendocrine tumors in high-risk surgical patients: Data from a single-center cohort 326
Male breast MRI: a review of different pathological conditions 293
Autoimmune Pancreatitis: Differences Between the Focal and Diffuse Forms in 87 Patients 288
A Rare Case of Pancreatic Head Splenosis Diagnosed by Contrast-Enhanced Ultrasound 288
Ablation Difficulty Score: Proposal of a new tool to predict success rate of percutaneous ablation for hepatocarcinoma 274
Can histogram analysis of MR images predict aggressiveness in pancreatic neuroendocrine tumors? 269
A phase II study of liposomal irinotecan with 5-fluorouracil, leucovorin and oxaliplatin in patients with resectable pancreatic cancer: the nITRO trial 268
7T MRI and histology reveal early tissue and perfusion changes after radiofrequency ablation in a murine colorectal cancer model 266
Acoustic Radiation Force Impulse (ARFI) technique in ultrasound with Virtual Touch tissue quantification of the upper abdomen 260
CT Enhancement and 3D Texture Analysis of Pancreatic Neuroendocrine Neoplasms 254
Are Cystic Pancreatic Neuroendocrine Tumors an Indolent Entity? Results from a Single-Center Surgical Series 249
Tumor-like lesionsof the pancreas. 248
The Evolution of Surgical Strategies for Pancreatic Neuroendocrine Tumors (Pan-NENs): Time-trend and Outcome Analysis From 587 Consecutive Resections at a High-volume Institution. 248
Diagnostic Performance of Contrast-Enhanced Ultrasound (CEUS) and Contrast-Enhanced Endoscopic Ultrasound (ECEUS) for the Differentiation of Pancreatic Lesions: A Systematic Review and Meta-Analysis 243
3D-CT texture analysis of neuroendocrine pancreatic neoplasms 243
Evaluation of liver injury with MRI after chemotherapy 242
Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma 242
Acoustic radiation force impulse (ARFI) ultrasound imaging of pancreatic cystic lesions 239
Bcl-10, trypsin and synaptophysin helps recognize acinar cell and mixed acinar neuroendocrine cell carcinoma of the pancreas on both preoperative cytological samples and needle biopsy specimens 239
Comparison of imaging-based and pathological dimensions in pancreatic neuroendocrine tumors 237
Perfusion Changes in Liver Metastases (LM) from Pancreatic Neuroendocrine Tumors (PanNETs) during Everolimus (E) Treatment: Update of Perfusion CT (P-CT) Study 232
Downstaging in Stage IV Pancreatic Cancer: A New Population Eligible for Surgery? 232
Acoustic radiation force impulse of the liver 231
A 25 years longitudina study of hepatitis B e antigen positive chornic hepatitis B in italian patients 229
Endovascular management of splanchnic arteries bleeding in pancreato-biliary disease 229
Chapter 73: Imaging of the Pancreas 228
Is there a role for near-infrared technology in laparoscopic resection of pancreatic neuroendocrine tumors? Results of the COLPAN "colour-and-resect the pancreas" study 227
Acoustic radiation force impulse imaging of focal pancreatic lesions 227
Acoustic radiation force impulse (ARFI) imaging in the pre-operative liver function evaluation in patients candidate to liver resection 226
Focal liver lesions: sinusoidal phase of CEUS. 225
Accurancy of CEUS in the caracterization of focal pancreatic lesions 224
Tumor Perfusion Changes During Everolimus (E) Treatment: Preliminary Results from Perfusion-CT (P-CT) Study 223
Radiofrequency ablation for locally advanced pancreatic cancer: SMAD4 analysis segregates a responsive subgroup of patients 223
Tumor thrombosis: a peculiar finding associated with pancreatic neuroendocrine neoplasms. A pictorial essay 223
Autoimmune pancreatitis: instrumental diagnosis 222
Il distretto renale 221
A Rare Case of Incidental Pancreatic Arteriovenous Malformation Correctly Diagnosed with MDCT 221
Contrast Enhanced Ultrasonography vs. Spiral CT in the detection of the vascularization of solid pancreatic lesions. 220
Comparison between CT perfusion and indocyanine green retention test: time to peak values can provide a non-invasive esteem of liver function 220
In vivo mapping of histological and vascular aspect of mammary tumors in transgenic mice using MRI and ultrasonography 218
An Overview of Artificial Intelligence Applications in Liver and Pancreatic Imaging 218
Acinar Cystic Transformation of the Pancreas: Histomorphology and Molecular Analysis to Unravel its Heterogeneous Nature 214
Correlation of MR features and histogram-derived parameters with aggressiveness and outcomes after resection in pancreatic ductal adenocarcinoma 214
Radiofrequency ablation of HCC: CT texture analysis of the ablated area to predict local recurrence 213
Contrast-enhanced ultrasonography (CEUS) vs. MRI of the small bowel in the evaluation of Crohn's disease activity. 213
Cholangiocarcinoma Heterogeneity Revealed by Multigene Mutational Profiling: Clinical and Prognostic Relevance in Surgically Resected Patients 212
Can CT texture analysis predict resectability and surgical outcomes after neoadjuvant radiotherapy in pancreatic cancer patients? 211
Comparison between CT texture data, resection margin status and clinical outcomes in pancreatic adenocarcinoma resected after induction chemotherapy and neoadjuvant stereotactic body radiation therapy 210
3D CT texture analysis of neuroendocrine pancreatic neoplasms 209
In vivo mapping of spontaneous mammary tumors in transgenic mice using MRI and ultrasonography 208
Elastography of the pancreas 206
Acoustic radiation force impulse with shear wave speed quantification of pancreatic masses: A prospective study 206
Dual-tracer (68Ga-DOTATOC and 18F-FDG-)-PET/CT scan and G1-G2 non-functioning pancreatic neuroendocrine tumors: A single-center retrospective evaluation of 124 non-metastatic resected cases 206
Accuracy of VirtualTouch Acoustic Radiation Force Impulse (ARFI) Imaging for the Diagnosis of Cirrhosis during Liver Ultrasonography 205
Non-Invasive Diagnosis of Hepatocellular Carcinoma 205
Italian consensus guidelines for the diagnostic work-up and follow-up of cystic pancreatic neoplasms 205
Perfusion CT Changes in Liver Metastases from Pancreatic Neuroendocrine Tumors During Everolimus Treatment 204
Guidelines and Good Clinical Practice Recommendations for Contrast Enhanced Ultrasound (CEUS) in the Liver - Update 2020 - WFUMB in Cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS 204
Ruolo della fistolografia nella caratterizzazione delle fistole pancreatiche post duodenocefalopancreasectomia 203
Role of coronary angiography MDCT in the clinical setting: changes in diagnostic workup in the real world. 203
Cystic lesions of the pancreas: CEUS, MRI and MRCP features 203
ESGAR 2016 Book of Abstracts 203
Neuroendocrine Neoplasms 203
Molteplici e sincrone neoplasie del tratto gastroenterico in un paziente affetto da neurofibromatosi di tipo 1 202
Oncocytic Intraductal Papillary Mucinous Neoplasms of the Pancreas: Imaging and Histopathological Findings 201
Role of Combined Ga-68-DOTATOC and F-18-FDG Positron Emission Tomography/Computed Tomography in the Diagnostic Workup of Pancreas Neuroendocrine Tumors Implications for Managing Surgical Decisions 201
Ablation treatments in unresectable pancreatic cancer 201
'Case of the Month' from the University of Verona, Italy-navigating the medical and surgical challenges of urinary bladder paraganglioma: insights from a clinical case 201
Valutazione comparativa dell'acquisizione volumetrica tiroidea con ecografia convenzionale B-Mode (US) ed ecografia volumetrica (VUS) 200
Behavior of hepatocellular adenoma on real-time low-mechanical index contrast-enhanced ultrasonography with a second-generation contrast agent 200
La TC a doppia energia nel follow-up dell’epatocarcinoma trattato mediante termo-ablazione percutanea 199
Contrast-enhanced US of hepatocellular carcinoma 199
Identification of liver fibrosis in chronic hepatitis: accuracy of US 199
Pancreatic neuroendocrine neoplasms: Magnetic resonance imaging features according to grade and stage 199
Acoustic radiation force impulse US imaging of liver fibrosis 198
Tumor seeding after percutaneous US-guided FNA of solid pancreatic neoplasms 198
Pancreas 198
Histogram analysis of magnetic resonance images: evaluation of intra-tumoral heterogeneity and correlation with pathological findings in solid pancreatic tumors. 198
Hypoechoic focal liver lesions: characterization with contrast enhanced ultrasonography 197
Comparison between CT perfusion and indocyanine green retention test results in the assessment of hepatic function 197
Ultrasonography of the pancreas. 3. Doppler imaging. 195
Comparison between CT perfusion and indocyanine green retention test results in the assessment of hepatic function 195
Acute pancreatitis after pancreatoduodenectomy: A prospective study of diffusion-weighted magnetic resonance imaging, serum biomarkers, and clinical features 194
Acoustic Radiation Force Impulse (ARFI) of the pancreas 194
Palliative therapy in pancreatic cancer-interventional treatment with radiofrequency ablation/irreversible electroporation 194
Autoimmune pancreatitis: Multimodality non-invasive imaging diagnosis 194
Contrast-enhanced ultrasonography better identifies pancreatic tumor vascularization than helical CT 193
CEUS of the pancreas: Still research or the standard of care 192
Totale 24.841
Categoria #
all - tutte 258.589
article - articoli 144.102
book - libri 0
conference - conferenze 90.317
curatela - curatele 1.326
other - altro 559
patent - brevetti 0
selected - selezionate 0
volume - volumi 22.285
Totale 517.178


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.128 0 0 0 183 287 82 44 188 108 90 317 829
2022/20237.758 522 732 659 1.438 617 1.863 133 576 882 57 182 97
2023/20243.679 159 317 332 360 457 571 180 309 55 172 538 229
2024/20259.530 508 669 407 1.466 501 294 524 494 1.274 602 839 1.952
2025/202630.689 2.114 1.624 2.578 5.105 7.449 2.158 2.666 1.508 2.370 1.608 531 978
2026/20277.001 631 986 1.385 3.999 0 0 0 0 0 0 0 0
Totale 80.793